ICD-10 Code C86.4 | Blastic NK-cell lymphoma Symptoms, Diagnosis, Billing

Blastic NK-cell lymphoma is a rare and aggressive form of non-Hodgkin lymphoma characterized by the proliferation of blastic natural killer (NK) cells. It is associated with immunosuppression and can present with systemic symptoms such as fever, weight loss, and lymphadenopathy. Accurate coding with ICD-10 Code C86.4 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat this condition.

What is ICD-10 Code C86.4 for Blastic NK-cell lymphoma?

ICD-10 Code C86.4 specifically denotes Blastic NK-cell lymphoma, a hematological malignancy arising from NK cells. This code should be used when documenting cases of this aggressive lymphoma, particularly when patients exhibit symptoms such as lymphadenopathy or systemic manifestations. Proper use of this code in clinical documentation and billing is crucial for accurate patient management and reimbursement.

ICD-10 Code C86.4 – Clinical Definition and Explanation of Blastic NK-cell lymphoma

Blastic NK-cell lymphoma is a highly aggressive neoplasm that arises from natural killer cells, often presenting in immunocompromised individuals. The disease can progress rapidly, leading to significant morbidity and mortality, necessitating prompt medical intervention.

Key Clinical Features:

• Rapidly enlarging lymph nodes, often in the cervical region.
• Systemic symptoms such as fever, night sweats, and weight loss.
• Cytopenias due to bone marrow infiltration.
• Potential skin lesions or extranodal involvement.

ICD-10 Code C86.4 for Blastic NK-cell lymphoma – SOAP Notes & Clinical Use

In SOAP notes, ICD-10 Code C86.4 is utilized to document the diagnosis of Blastic NK-cell lymphoma, aiding in the assessment of symptoms, treatment plans, and patient outcomes. This code is relevant in both acute and chronic care settings, ensuring comprehensive patient management.

What Does ICD-10 Code C86.4 for Blastic NK-cell lymphoma Mean in SOAP Notes?

ICD-10 Code C86.4 connects subjective patient reports and objective clinical findings to a formal diagnosis of Blastic NK-cell lymphoma. This code is essential for ensuring continuity of care, supporting billing processes, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code C86.4 – Blastic NK-cell lymphoma

Blastic NK-cell lymphoma requires urgent medical attention, often necessitating hospitalization for intensive treatment. Standard therapeutic approaches include chemotherapy and targeted therapies.

Antibiotic Therapy:

• Not applicable as Blastic NK-cell lymphoma is not an infectious disease.

Supportive Care:

• Management of symptoms such as pain and fever.
• Transfusions for cytopenias.
• Nutritional support and counseling.

Infection Control:

• Implement standard precautions to prevent infections.
• Monitor for signs of febrile neutropenia.

How to Document Symptoms of Blastic NK-cell lymphoma (ICD-10 C86.4) in SOAP Notes

Subjective:

• Patient reports persistent fatigue and unexplained weight loss.
• Complaints of night sweats and fever.
• Notable increase in size of cervical lymph nodes.
• History of recurrent infections.

Objective:

• Physical examination reveals enlarged cervical lymph nodes.
• Complete blood count shows leukopenia and anemia.
• Imaging studies indicate lymphadenopathy and possible splenomegaly.
• Bone marrow biopsy confirms NK-cell infiltration.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Blastic NK-cell lymphoma (ICD-10 Code C86.4)

Assessment:

• Diagnosis of Blastic NK-cell lymphoma, aggressive subtype.
• ICD-10 Code C86.4 applied for billing and documentation.
• Contributing factors include immunosuppression.

Plan:

• Initiate chemotherapy regimen as per oncology guidelines.
• Provide education on disease process and treatment options.
• Schedule regular follow-up appointments for monitoring.
• Consider referral to palliative care for symptom management.

Treatment & Plan Section for ICD-10 Code C86.4 – Blastic NK-cell lymphoma

• First-line pharmacologic treatments include multi-agent chemotherapy regimens.
• Non-pharmacologic strategies involve nutritional support and psychosocial counseling.
• Monitoring practices include regular CBC checks and imaging studies.
• Follow-up recommendations should include assessments for treatment response and side effects.

Using ICD-10 Code C86.4 for Blastic NK-cell lymphoma in Billing & SOAP Note Compliance

• Select appropriate ICD-10 code based on clinical findings and documentation.
• Ensure Subjective (S) and Objective (O) sections clearly reflect the diagnosis.
• Align treatment plans with clinical guidelines to support justified billing.
• Document all relevant CPT codes that correspond with the treatment provided.

Related ICD-10 Codes Often Used with Blastic NK-cell lymphoma

• C86.0 – Peripheral T-cell lymphoma, unspecified

ICD-10 Code C86.4 in Medical Billing and Insurance for Blastic NK-cell lymphoma

ICD-10 Code C86.4 is critical in medical billing, particularly in hospital, emergency room, or infectious disease care settings.

Billing Notes:

• Document all relevant clinical findings to support the use of C86.4.
• Ensure accurate coding based on the patient's clinical presentation.
• Include detailed notes on treatment plans and patient education.
• Utilize the code in conjunction with appropriate CPT codes for billing.

Common CPT Pairings: